Sunflower Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,904
Closed -$201K 110
2023
Q1
$201K Sell
2,904
-402
-12% -$28.4K 0.05% 109
2022
Q4
$238K Sell
3,306
-311
-9% -$23.4K 0.05% 103
2022
Q3
$258K Sell
3,617
-1,759
-33% -$128K 0.06% 105
2022
Q2
$414K Sell
5,376
-5,738
-52% -$437K 0.08% 97
2022
Q1
$812K Buy
11,114
+650
+6% +$43.6K 0.11% 79
2021
Q4
$653K Sell
10,464
-77
-0.7% -$4.52K 0.09% 95
2021
Q3
$624K Sell
10,541
-2,283
-18% -$150K 0.09% 97
2021
Q2
$857K Sell
12,824
-465
-3% -$30.3K 0.13% 83
2021
Q1
$839K Sell
13,289
-440
-3% -$27.4K 0.14% 79
2020
Q4
$851K Buy
13,729
+8,619
+169% +$530K 0.15% 73
2020
Q3
$308K Sell
5,110
-296
-5% -$17.8K 0.12% 71
2020
Q2
$317K Buy
+5,406
New +$323K 0.13% 70

Other funds holding BMY

Sunflower Bank's BMY Position: Q2 2023 in Review

Sunflower Bank sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 2,904 shares — an estimated $201K sold.

Sunflower Bank first reported a position in BMY in Q2 2020 and held it in 12 quarters. The position peaked at $857K in Q2 2021. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Sunflower Bank reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
  • Sunflower Bank sold 2,904 Bristol-Myers Squibb shares in Q2 2023, an estimated $201K.
  • Sunflower Bank first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 12 quarters.
  • Sunflower Bank's Bristol-Myers Squibb position peaked at $857K in Q2 2021.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Sunflower Bank's 13F filing for Q2 2023, filed 13 Jul 2023.